Dr Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases and the US President's chief medical adviser, has said that he believes the AstraZeneca (LON:AZN) COVID-19 vaccine should be accepted by the US under its new travel rules, BBC News reported on Tuesday.
Currently, the US regulator does not recommend the AstraZeneca vaccine for use in the US.
However Dr Fauci said he knows there is a lot of data available on the vaccine.
Dr Fauci told BBC Radio 4's Today programme that given the fact the situation in the US is comparable with so many other countries, including the UK, the government wants to have a uniform policy of requiring vaccinations and testing.
Also, Dr Fauci added that the sooner the world gets vaccinated the "greater the chance we will get of not allowing variants to emerge".
According to Dr Fauci, it is less to do with travel and more to do with getting everyone vaccinated.
Inimmune signs research collaboration with Boston Children's Hospital
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
AllerVie Health Rebrands Southern Allergy & Asthma
Applied BioCode Inks Distribution Agreement with Medline Industries
Vedanta Biosciences Receives Fast Track Designation for VE303
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary